Qiu-ming Wang
Dalian, 116011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Erratum: Inhibition of P-glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension.
Journal: Experimental and therapeutic medicine
Published: April 28, 2022
Correction to "Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation".
Journal: World journal of gastroenterology
Published: February 24, 2022
Inhibition of P-glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension.
Journal: Experimental and therapeutic medicine
Published: September 11, 2015
Endogenous carbon monoxide downregulates hepatic cystathionine-γ-lyase in rats with liver cirrhosis.
Endogenous carbon monoxide downregulates hepatic cystathionine-γ-lyase in rats with liver cirrhosis.
Journal: Experimental and therapeutic medicine
Published: October 01, 2014
Octreotide attenuates liver fibrosis by inhibiting hepatic heme oxygenase-1 expression.
Journal: Molecular medicine reports
Published: November 28, 2013
A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy.
Journal: Experimental and therapeutic medicine
Published: February 13, 2013
Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation.
Journal: World journal of gastroenterology
Published: January 13, 2013
Heme oxygenase/carbon monoxide pathway inhibition plays a role in ameliorating fibrosis following splenectomy.
Journal: International journal of molecular medicine
Published: December 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026